Taro Pharmaceutical Industries Ltd.

NYSE:TARO

42.975 (USD) • At close June 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988
Revenue 629.182572.952561.347548.97644.769669.893661.913879.387950.751862.944759.285670.954543.082392.535357.643329.036319.554252.269297.743284.13315.458211.581150.134103.79783.78566.76156.549.642.128.526.520.613.311.89.28.8
Cost of Revenue 324.203304.629268.225252.314245.044224.169198.405208.136171.785186.359179.279176.128177.497159.158154.774148.344133.399123.516128.69119.404102.45479.46854.73635.33930.90326.325.922.719.115.712.512.29.56.965.15
Gross Profit 304.979268.323293.122296.656399.725445.724463.508671.251778.966676.585580.006494.826365.585233.377202.869180.692186.155128.753169.053164.726213.004132.11395.39868.45852.88240.435.133.830.526.41614.311.16.45.84.13.8
Gross Profit Ratio 0.4850.4680.5220.540.620.6650.70.7630.8190.7840.7640.7370.6730.5950.5670.5490.5830.510.5680.580.6750.6240.6350.660.6310.6060.5750.5980.6150.6270.5610.540.5390.4810.4920.4460.432
Reseach & Development Expenses 64.53652.24354.5460.15259.77763.23870.41870.64471.1665.5155.4346.50833.45636.39334.24335.04429.81736.27345.76741.94340.60126.37319.63314.59311.7289.29.78.9000000000
General & Administrative Expenses 085.08657.05752.81356.75783.44478.28300081.94679.2250000000000000000000000000
Selling & Marketing Expenses 0113.2856.6238.54236.6566.5279.9130009.7877.2130000000000000000000000000
SG&A 218.935198.366113.67691.35593.41389.97188.19685.65692.36587.64491.73386.43894.559107.902102.20299.02597.274109.048108.099123.29997.71852.48142.9931.90225.93320.71817.723.417.913.611.77.75.14.73.53.5
Other Expenses 64.5362.4624.2262.8923.0181.811.88911.2112.682.7381.3693.3520.7842.6173.3632.82027.9230000004.4114.13.32.41.81.410.70.50.40.60.30
Operating Expenses 283.471250.609168.216151.507153.19153.209158.614156.3163.525153.154147.163132.946128.015144.295136.445134.069127.091145.321153.866165.242138.31978.85462.62346.49542.07234312925.219.314.612.48.25.55.33.83.5
Operating Income 21.50817.714184.366704.438246.535296.193303.01514.951614.468527.631430.253328.58236.78686.46563.06143.80259.064-70.35315.187-0.51674.68553.25932.77516.09610.816.44.14.85.37.11.41.92.90.90.50.30.3
Operating Income Ratio 0.0340.0310.3281.2830.3820.4420.4580.5860.6460.6110.5670.490.4360.220.1760.1330.185-0.2790.051-0.0020.2370.2520.2180.1550.1290.0960.0670.0850.1070.1690.0490.0720.1410.0680.0420.0330.034
Total Other Income Expenses Net 75.3620.499-47.06-536.22251.560.661-10.64245.84722.35258.24913.6547.2834.148-11.085-15.9670.259-18.516-11.454-7.893-6.417-1.729-0.298-2.403-3.531-3.8-2.7-2.1-1.5-1.8-1.2-0.4-0.8-1.4-0.40.10.10.1
Income Before Tax 82.66838.21377.859-391.073298.035356.854292.368560.798636.82581.68443.907335.863240.93475.3847.09444.06240.548-81.8077.294-6.93372.95652.96130.37212.5657.013.723.33.55.911.11.50.50.60.40.4
Income Before Tax Ratio 0.1310.0670.139-0.7120.4620.5330.4420.6380.670.6740.5850.5010.4440.1920.1320.1340.127-0.3240.024-0.0240.2310.250.2020.1210.0840.0550.0330.0580.0710.140.0350.0420.0730.0380.0510.0430.045
Income Tax Expense 28.80112.76819.5929.66753.48574.73281.954103.7895.31396.05982.72967.79935.97410.477-69.65713.5416.2120.8721.617-16.99111.4758.4064.3782.5381.4711.40.61.11.52.50.80.70.71.10.70.20.4
Net Income 53.86725.44558.266-400.74244.241281.777211.15456.356540.932484.257360.387266.206204.27464.078114.02330.52134.336-82.6795.67711.07561.15544.55525.99410.0275.5392.31.42.223.40.20.90.8-0.2-0.20.10
Net Income Ratio 0.0860.0440.104-0.730.3790.4210.3190.5190.5690.5610.4750.3970.3760.1630.3190.0930.107-0.3280.0190.0390.1940.2110.1730.0970.0660.0340.0230.0390.040.0810.0070.0340.039-0.015-0.0170.0110
EPS 1.430.681.55-10.496.357.235.2611.0512.6211.318.145.961.061.592.910.780.99-2.820.190.382.121.551.110.470.280.120.070.110.10.180.010.050.055-0.015-0.0150.010
EPS Diluted 1.430.681.55-10.496.357.235.2611.0512.6211.318.145.951.061.532.810.760.98-2.820.190.372.061.520.990.420.260.120.070.110.0950.170.010.050.055-0.015-0.0150.010
EBITDA 38.40252.654164.887-413.775305.305282.125303.01509.612624.194493.395444.882328.58249.644108.89484.86967.80982.84-17.31840.46718.90174.68561.58339.26127.37415.12710.47.27.17.18.522.63.71.710.50.3
EBITDA Ratio 0.0840.0920.3751.3260.3930.4210.5370.580.6570.5720.5860.6120.460.2770.2370.2060.259-0.0690.1360.0670.2790.2910.2620.2640.1810.1560.1180.1260.1430.2020.070.0980.180.1280.0850.0540.034